TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 19TH EDITIONBY MICHELLE J. WILLIHNGANZ, SAMUEL L. GUREVITZ, BRUCE CLAYTON COMPLETE

TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR
NURSES 19TH EDITIONBY MICHELLE J. WILLIHNGANZ,
SAMUEL L. GUREVITZ, BRUCE CLAYTON COMPLETE

,Chapter 01: Drug Definitions, Standards, and Information Sources
Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition


MULTIPLE CHOICE

1. Which name identifies a drug listed by the US Food and
Drug Administration (FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C
The official name is the name under which a drug is listed
by the FDA. The brand name, or trademark, is the name
given to a drug by its manufacturer. The nonproprietary, or
generic, name is provided by the United States Adopted
Names Council.

DIF: Cognitive Level: Knowledge REF: p. 9
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care
Environment TOP: Nursing Process Step: Assessment CON:
Patient Education

2. Whichtysourcetycontainstyinformationtyspecifictytotynutritionaltysupplements?
a. USPtyDictionarytyoftyUSANt y &tyInternationaltyDrugtyNames
b. NaturaltyMedicinestyComprehensivetyDatabase
c. UnitedtyStatestyPharmacopoeia/NationaltyFormularyty(USPtyNF)
d. DrugtyInteractiontyFacts
ANS:t yC
UnitedtyStatestyPharmacopoeia/NationaltyFormularytycontainstyinformationtyspecifictytotynutritiona
ltsy upplements.tyUSPtyDictionarytyoftyUSANty&tyInternationaltyDrugtyNamestyistyatycompilationtyoftydr
ugtny ames,typronunciationtyguide,tyandtypossibletyfuturetyFDAtyapprovedtydrugs;tyittydoestynottyinclud
etynutritionaltysupplements.tyNaturaltyMedicinestyComprehensivetyDatabasetycontains
evidence-
basedtyinformationtyontyherbaltymedicinestyandtyherbaltycombinationtyproducts;tyittydoestynottiy ncludetyi
nformationtyspecifictytotynutritionaltysupplements.tyDrugtyInteractiontyFactstycontainstycomprehens
ivetyinformationtyontydrugtyinteractiontyfacts;tyittydoestynottyincludetynutritionaltysupplements.

DIF: CognitivetyLevel:tyKnowledge REF:t y p.ty4
OBJ:ty3tN
y AT:t y NCLEXtyClienttyNeedstyCategory:tyPhysiologicaltyInt

egrity
TOP:t y NursingtyProcesstyStep:tyAssessment CON:t y Nutritionty|tyPatienttyEducation

3. Whichtydrugtyreferencetycontainstydrugtymonographstythattydescribetyalltydrugstyintyatytherapeutictyclass?
a. DrugtyFactstyandtyComparisons

,TesttyBanktyFortyClayton’styBasictyPharmacologytyfortyNursesty19thtyEditi 3
on
b. DrugtyInteractiontyFacts
c. HandbooktyontyInjectabletyDrugs
d. Martindale—ThetyCompletetyDrugtyReference
ANS:t y A
DrugtyFactstyandtyComparisonstycontainstydrugtymonographstythattydescribetyalltydrugstyinty
atty herapeutictyclass.tyMonographstyaretyformattedtyastytablestytotyallowtycomparisontyoftysimil
artpy roducts,tybrandtynames,tymanufacturers,tycosttyindices,tyandtyavailabletydosagetyformsty
Onlinetyversiontyistyavailable.

DIF: CognitivetyLevel:tyKnowledge REF:t y p.ty4tyTablety1.2
OBJ:tytyt y 3 NAT:t y NCLEXtyClienttyNeedstyCategory:tyPhysiologicaltyIntegrity
TOP:t y NursingtyProcesstyStep:tyAssessment CON:t y Safetyty|tyPatienttyEducationty|tyClinicaltyJudgment

4. Whichtydrugtyreferencetycontainstymonographstyaboutt yvirtuallytyeverytysingle-
entitytydrugtyavailableity ntythetyUnitedtyStatestyandtydescribestytherapeutictyusestyoftydrugs,tyincluding
tyapprovedtyandtyunapprovedtyuses?

a. Martindale:tyThetyCompletetyDrugtyReference
b. AHFStyDrugtyInformation
c. DrugtyReference
d. DrugtyFactstyandtyComparisons
ANS:t y B
AHFStyDrugtyInformationtycontainstymonographstyabouttyvirtuallytyeverytysingle-
entitytydrugtyavailabletyintythetyUnitedtyStatestyandtydescribestytherapeutictyusestyoftydrugs,tyincludingty
approvedtyandtuy napprovedtyuses.

DIF: CognitivetyLevel:tyKnowledge REF:t y p.ty4tyTablety1.2
OBJ:tytyt y 3 NAT:t y NCLEXtyClienttyNeedstyCategory:tyPhysiologicaltyIntegrity
TOP:t y NursingtyProcesstyStep:tyPlanning CON:t y Safetyty|tyPatienttyEducationty|tyClinicaltyJudgment

5. Whichtyonlinetydrugtyreferencetymakestyavailabletytotyhealthcaretyproviderstyandtythetypublictyatys
tandard,tycomprehensive,tyup-to-datetylooktyuptyandtydownloadabletyresourcetyabouttymedicines?
a. AmericantyDrugtyIndex
b. AmericantyHospitaltyFormulary
c. DailyMed
d. DrugtyReference
ANS:t yC
DailyMedtymakestyavailabletytotyhealthcaretyproviderstyandtythetypublictyatystandard,tycomprehensiv
e,tuy p-to-
datetylooktyuptyandtydownloadabletyresourcetyabouttymedicines.tyThetyAmericantyDrugtyIndextyistny ottya
ppropriatetyfortypatienttyuse.tyThetyAmericantyHospitaltyFormularytyistynottyappropriatetyfortypatient
tyuse.tyThetydrugtyreferencety istynottyappropriatetyfortypatienttyuse.




DIF: CognitivetyLevel:tyKnowledge REF:t y p.ty3ty|typ.ty4
OBJ:ty3tN
y AT:t y NCLEXtyClienttyNeedstyCategory:tyPhysiologicaltyInt

egrity
TOP:t y NursingtyProcesstyStep:tyImplementation
CON:t y Safetyty|tyPatienttyEducationty|tyClinicaltyJudgment

6. WhichtylegislationtyauthorizestythetyFDAtytotydeterminetythetysafetytyoftyatydrugtybeforetyitstymarketing?
a. FederaltyFood,tyDrug,tyandtyCosmetictyActty(1938)
b. DurhamtyHumphreytyAmendmentty(1952)

, TesttyBanktyFortyClayton’styBasictyPharmacologytyfortyNursesty19thtyEditi 4
on
c. ControlledtySubstancestyActty(1970)
d. KefauvertyHarristyDrugtyAmendmentty(1962)
ANS:t y A
ThetyFederaltyFood,tyDrug,tyandtyCosmetictyActtyofty1938tyauthorizedtythetyFDAtytotydeterminetythetys
afetytyoftyalltydrugstybeforetymarketing.tyLatertyamendmentstyandtyactstyhelpedtytightentyFDAtycontro
ltyandtyensuretydrugtysafety.tyThetyDurhamtyHumphreytyAmendmenttydefinestythetykindstyoftydrugstyth
attycannottybetyusedtysafelytywithouttymedicaltysupervisiontyandtyrestrictstytheirtysaletytotyprescriptionty
bytyatylicensedtypractitioner.tyThetyControlledtySubstancestyActtyaddressestyonlytycontrolledtysubstan
cestyandtty heirtycategorization.tyThetyKefauvertyHarristyDrugtyAmendmenttyensurestydrugtyefficacytyan
dtygreatertdy rugtysafety.tyDrugtymanufacturerstyaretyrequiredtytotyprovetytotythetyFDAtythetyeffectivenes
styoftytheirtyproductstybeforetymarketingtythem.

DIF: CognitivetyLevel:tyKnowledge REF:typ.ty5tyTabletyl.3
OBJ:t y 5
NAT:tyNCLEXtyClienttyNeedstyCategory:tyPhysiologicaltyIntegrit
ytT
y OP:t y NursingtyProcesstyStep:tyAssessment

CON:t y Safetyty|tyPatienttyEducationty|tyEvidencety|tyHealthtyCaretyLaw

7. Whichtyclassificationtydoestymeperidinety(Demerol)tyfalltyunder?
a. I
b. II
c. III
d. IV
ANS:t y B
Meperidinety(Demerol)tyistyatyScheduletyIItydrug;tyittyhastyatyhightypotentialtyfortyabusetyandtymaytylead
tytots
y everetypsychologicaltyandtyphysicaltydependence.tyScheduletyItydrugstyhavetyhightypotentialtyfortya

busetay ndtynotyrecognizedtymedicaltyuse.tyScheduletyIIItydrugstyhavetysometypotentialtyfortyabuse.tyUset
ymaytyleadtytotylowtytotymoderatetyphysicaltydependencetyortyhightypsychologicaltydependence.tySche

duletyIVtdy rugstyhavetylowtypotentialtyfortyabuse.tyUsetymaytyleadtytotylimitedtyphysicaltyortypsychologi
caltydependence.

DIF: CognitivetyLevel:tyKnowledge REF:t y p.ty10
OBJ:ty2tyNAT:t y NCLEXtyClienttyNeedstyCategory:tySafe,tyEffectivetyC
aretyEnvironment
TOP:t y NursingtyProcesstyStep:tyAssessment CON:t y PatienttyEducationty|tyAddictionty|tyPain

8. WhichtyactiontywouldtythetyFDAtytaketytotyexpeditetydrugtydevelopmentt yandtyapprovaltyfortyantyoutbre
akoty ftysmallpox?
a. Listtysmallpoxtyastyatyhealthtyorphantydisease.
b. Omittythetypreclinicaltyresearchtyphase.
c. Extendtythetyclinicaltyresearchtyphase.
d. Fasttytracktythetyinvestigationaltydrug.
ANS:t yD
OncetythetyInvestigationaltyNewtyDrugtyApplicationtyhastybeentyapproved,tythetydrugtycantyreceivetyhi
ghesttyprioritytywithintythetyagency,tywhichtyistycalledtyfasttytracking.tyAtysmallpoxtyoutbreaktywouldty
becometyatyprioritytyconcerntyintythetyworld.tyOrphantydiseasestyaretynottyresearchedtyintyatyprioritytym
anner.tyPreclinicaltyresearchtyistynottyomitted.tyExtendingtyanytyphasetyoftythetyresearchtywouldtymeanty
atylongertytimetytotydeveloptyatyvaccine.tyThetyFDAtymusttyensuretythattyalltyphasestyoftythetypreclinicaltyan
dtcy linicaltyresearchtyphasetyhavetybeentycompletedtyintyatysafetymanner.

DIF: CognitivetyLevel:tyKnowledge REF:tytytyp.ty7 OBJ:t y 5